Tufts HEOR Certificate Program Taking Applications
The Tufts Graduate School of Biomedical Sciences and Clinical and Translational Science offers a Health Economics and Outcomes Research (HEOR) [...]
CDC’s Updated Mask Recommendation Leads to Criticism; Changes to COVID-19 Reporting Structure
The Centers for Disease Control (CDC) recently put forth updated mask recommendations; vaccinated people no longer need to wear a [...]
Upcoming HealthVerity Event on RWD in Rare Disease Drug Development Pipeline
Using real world data (RWD) in rare disease research offers a method to circumvent many of the traditional challenges facing [...]
Johnson & Johnson RWE Expert Shares Thoughts on Transparency
In a recent interview, Jesse Berlin of Johnson & Johnson discusses how real world evidence (RWE) has shifted the research [...]
HTAs Consider the Incorporation of RWE in Drug Assessments
A new edition of industry news highlights focuses on health technology assessments (HTAs) and their growing acceptance of real world [...]
Woman to Woman Podcast Series Highlights Senior HEOR Researcher
Divya Yerraguntla hosts a podcast series that highlights the stories of women who have broken through barriers to succeed in [...]
HealthEconomics.Com President Leads Discussion on New Scientist.com’s Value, Evidence and Access Marketplace, Notes Substantial Cost Benefits
HealthEconomics.Com President Dr. Patti Peeples spoke with Scientist.com Category Directory Maria Negron and Senior Director of Business Development David Brown. [...]
Upcoming Discussion on the Role of AI in Healthcare, COVID-19, and Equity
STAT recently published a report on artificial intelligence (AI), noting potential benefits such as lower healthcare costs and earlier disease [...]
BCG Report on Using RWE in Clinical Trials
A Boston Consulting Group (BCG) report discusses the benefits of real world evidence (RWE) in streamlining the clinical trial pipeline. [...]
HealthVerity Discusses How the COVID-19 Pandemic Accelerated RWD and RWE Trends in Drug Development
The COVID-19 pandemic has hastened industry trends when it comes to using real world data (RWD) and real world evidence [...]
New Report Offers Global Market Insight and Highlights Critical HEOR RWD Trends
A new report discusses health economics and outcomes research (HEOR) trends expected to impact the global economy for the next [...]
Does Hydroxychloroquine Work? New COVID-19 Evidence Accelerator Report Uses RWD to Determine Patient Outcomes
The COVID-19 Evidence Accelerator has published a new report in PLOS One. The manuscript examines how hydroxychloroquine and azithromycin affect [...]
How Will Europe Use RWE in Regulatory Decisions and HTAs?
Aetion’s Senior Director of European Business Development Pierre Engel discusses trends in Europe’s use of real world evidence (RWE). He [...]
Aetion President and Co-Founder Discusses RWE in Recent Coronavirus Study
Aetion Co-Founder and President Jeremy Rassen discusses the use of real world evidence (RWE) in a recent Science paper. Researchers [...]
New Report Discusses RWD and RWE in Regulatory Approval Process, Notes 82% of Submissions Using RWE Gain Orphan Drug Designation
A report published in Clinical Pharmacology & Therapeutics discusses the use of RWD (real world data) and RWE (real world [...]
HealthVerity Clinical Trial Optimization Approach Considers RWD Advantages and Promotes Equity
RWD (real world data) is changing the way clinical trials are designed and conducted. HealthVerity discusses important consideration for using [...]
Certara’s Strategic Evidence & Value Communication Symposium On-Demand Webinar Now Available, Features RWE and KOL Engagement Discussion
Certara recently invited panel speakers to discuss industry trends related to data visualization, KOL (key opinion leader) engagement, value communication, [...]
Will Patient RWD Improve Cardiovascular Disease Outcomes?
Amgen and Datos Health have partnered to explore how RWD (real world data) can improve outcomes for heart disease patients. Using [...]
New eBook on Improving Patient-Centered Healthcare Using RWD
A new eBook offered by Optum discusses when it’s appropriate to use RWD (real world data) to improve healthcare outcomes. [...]
New Report on Utilizing RWE in Drug Development Pipeline Throughout the Globe
A new report by consulting group Roots Analysis has been published. It features insight on RWE (real world evidence) when [...]
New Webinar on RWE and Clinical Trials Now Available
HealthVerity is offering a new webinar on understanding the value of RWE (real world evidence). In addition to reducing the [...]
ICER to Consider Aetion RWE in Revision of Hereditary Angioedema Therapy Report
ICER (the Institute for Clinical and Economic Review) has announced its decision to utilize RWE (real world evidence) data in [...]
Considerations and Challenges for RWD Include Data Matching and Security
HealthVerity discusses several challenges when it comes to using deidentified patient data. Although using patient information can provide unique insight, [...]
IQVIA Announces New Virtual Series on Making the Most of RWE
IQVIA has announced a four-session webcast series on the use of RWE (real world evidence) in drug development leading to [...]
Certara Announces Symposium on RWE, Value Communication, and Strategic Evidence
Certara will hold a symposium on Wednesday, April 21st, from 12 PM to 2 PM EDT. The symposium is broken [...]